Literature DB >> 18415433

[Pharmacokinetics of intranasal Fentanyl.].

H W Striebel1, J Krämer, I Luhmann, I Rohierse-Hohler, A Rieger.   

Abstract

Entities:  

Year:  1993        PMID： 18415433     DOI： 10.1007/BF02527870

Source DB:  PubMed          Journal:  Schmerz        ISSN： 0932-433X            Impact factor:   1.107


× No keyword cloud information.
  18 in total

1.  Intranasal administration of nitroglycerin.

Authors:  A B Hill; C J Bowley; M L Nahrwold; P R Knight; M M Kirsh; J K Denlinger
Journal:  Anesthesiology       Date:  1981-04       Impact factor: 7.892

2.  Fentanyl concentrations in brain and serum during respiratory acid--base changes in the dog.

Authors:  S G Ainslie; J H Eisele; G Corkill
Journal:  Anesthesiology       Date:  1979-10       Impact factor: 7.892

3.  Decreased fentanyl and alfentanil dose requirements with age. A simultaneous pharmacokinetic and pharmacodynamic evaluation.

Authors:  J C Scott; D R Stanski
Journal:  J Pharmacol Exp Ther       Date:  1987-01       Impact factor: 4.030

4.  Comparative pharmacokinetics of fentanyl and alfentanil.

Authors:  S Bower; C J Hull
Journal:  Br J Anaesth       Date:  1982-08       Impact factor: 9.166

5.  [Biotransformation of fentanyl. III. Effect of chronic drug exposure on the distribution, metabolism and excretion in the rat].

Authors:  K A Lehmann; L Hunger; K Brandt; D Daub
Journal:  Anaesthesist       Date:  1983-04       Impact factor: 1.041

6.  Age and fentanyl pharmacokinetics.

Authors:  J B Bentley; J D Borel; R E Nenad; T J Gillespie
Journal:  Anesth Analg       Date:  1982-12       Impact factor: 5.108

7.  Oral transmucosal fentanyl citrate premedication in children.

Authors:  J B Streisand; T H Stanley; B Hague; H van Vreeswijk; G H Ho; N L Pace
Journal:  Anesth Analg       Date:  1989-07       Impact factor: 5.108

8.  Comparison of intravenous and intranasal sufentanil absorption and sedation.

Authors:  J H Helmers; H Noorduin; A Van Peer; L Van Leeuwen; W W Zuurmond
Journal:  Can J Anaesth       Date:  1989-09       Impact factor: 5.063

9.  EEG quantitation of narcotic effect: the comparative pharmacodynamics of fentanyl and alfentanil.

Authors:  J C Scott; K V Ponganis; D R Stanski
Journal:  Anesthesiology       Date:  1985-03       Impact factor: 7.892

10.  Plasma concentrations of midazolam in children following intranasal administration.

Authors:  E J Walbergh; R J Wills; J Eckhert
Journal:  Anesthesiology       Date:  1991-02       Impact factor: 7.892
View more
  8 in total

Review 1.  [Nasal application of fentanyl citrate as symptom control against breathlessness in palliative care--overview and case report].

Authors:  Thomas Sitte
Journal:  Wien Med Wochenschr       Date:  2009-12

2.  [A device for patient-controlled intranasal analgesia (PCINA).].

Authors:  H W Striebel; M Römer; W Philippi; R Schwagmeier
Journal:  Schmerz       Date:  1995-03       Impact factor: 1.107

3.  [Intranasal fentanyl for breakthrough cancer pain. A pilot study.].

Authors:  H W Striebel; A Wessel; A Rieger
Journal:  Schmerz       Date:  1993-09       Impact factor: 1.107

4.  Early pharmacokinetics of nasal fentanyl: is there a significant arterio-venous difference?

Authors:  Kristin Moksnes; Olav M Fredheim; Pål Klepstad; Stein Kaasa; Anders Angelsen; Turid Nilsen; Ola Dale
Journal:  Eur J Clin Pharmacol       Date:  2008-01-06       Impact factor: 2.953

5.  Formulations of fentanyl for the management of pain.

Authors:  Sina Grape; Stephan A Schug; Stefan Lauer; Barbara S Schug
Journal:  Drugs       Date:  2010       Impact factor: 9.546

6.  Role of intranasal fentanyl in breakthrough pain management in cancer patients.

Authors:  Wojciech Leppert
Journal:  Cancer Manag Res       Date:  2010-09-30       Impact factor: 3.989

7.  Pharmacokinetic Characterisation and Comparison of Bioavailability of Intranasal Fentanyl, Transmucosal, and Intravenous Administration through a Three-Way Crossover Study in 24 Healthy Volunteers.

Authors:  S Nardi-Hiebl; J W Ndieyira; Y Al Enzi; W Al Akkad; T Koch; G Geldner; C Reyher; L H J Eberhart
Journal:  Pain Res Manag       Date:  2021-11-29       Impact factor: 3.037

8.  Intranasal Fentanyl for Intervention-Associated Breakthrough Pain After Cardiac Surgery.

Authors:  Antti Valtola; Maisa Laakso; Henriikka Hakomäki; Brian J Anderson; Hannu Kokki; Veli-Pekka Ranta; Valtteri Rinne; Merja Kokki
Journal:  Clin Pharmacokinet       Date:  2021-03-09       Impact factor: 6.447
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.